PORT-7

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NamePORT-7
Drug Alias NameTT-4PORT-7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2b receptor antagonists
TargetsAdenosine A2b receptor
Therapy Area/IndicationsPancreatic NeoplasmsStomach NeoplasmsColorectal Neoplasms +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImpetis Biosciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTarus Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsStomach NeoplasmsColorectal Neoplasms +[4

Other Information

ATC CodeN/A
Related LinksN/A